• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性头颈癌的99mTc-HYNIC膜联蛋白V显像

99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma.

作者信息

Vermeersch Hubert, Loose David, Lahorte Christophe, Mervillie Kris, Dierckx Rudi, Steinmetz Neil, Vanderheyden Jean-Luc, Cuvelier Claude, Slegers Guido, Van de Wiele Christophe

机构信息

Department of Head and Neck Surgery, University Hospital Ghent, Belgium.

出版信息

Nucl Med Commun. 2004 Mar;25(3):259-63. doi: 10.1097/00006231-200403000-00008.

DOI:10.1097/00006231-200403000-00008
PMID:15094444
Abstract

In this study, the potential of 99mTc-HYNIC Annexin-V scintigraphy to visualize primary head and neck carcinoma was assessed and compared with computed tomography (CT) findings and histology. Eighteen patients suspected of having primary head and neck carcinoma underwent a spiral CT scan and 99mTc-HYNIC Annexin-V scintigraphy within 1 week of each other, followed by resection of the suspected lesion. Results obtained by CT and scintigraphy were compared vs. histopathology. The diagnosis was primary head and neck carcinoma in 18 patients, accompanied by lymph node involvement in seven patients. 99mTc-HYNIC Annexin-V uptake was identified in five patients on planar images and in 17 patients on tomographic images (single-photon emission computed tomography, SPECT), corresponding to the pathological regions identified by CT. In the remaining patient, CT and 99mTc-HYNIC Annexin-V scintigraphy were false negative. In 11 patients, SPECT and CT scan were concordant, identifying all primary lesions and two sites of lymph node involvement. In the six remaining patients, CT and SPECT accurately identified the primary lesion, but were discordant with regard to the existence of lymph node involvement. In five of six patients, SPECT failed to identify lymph node involvement, whereas CT scan did not. In the remaining patient, CT scan was false positive for lymph node involvement, whereas SPECT was not. In this series, 99mTc-HYNIC Annexin-V allowed for the visualization of all primary head and neck tumours identified by CT scan, but failed to identify most of the sites of lymph node involvement.

摘要

在本研究中,评估了99mTc-HYNIC膜联蛋白V闪烁显像用于可视化原发性头颈部癌的潜力,并与计算机断层扫描(CT)结果及组织学进行比较。18例疑似原发性头颈部癌的患者在彼此相隔1周内分别接受了螺旋CT扫描和99mTc-HYNIC膜联蛋白V闪烁显像,随后切除疑似病变。将CT和闪烁显像获得的结果与组织病理学结果进行比较。18例患者的诊断均为原发性头颈部癌,其中7例伴有淋巴结受累。在平面图像上有5例患者、在断层图像(单光子发射计算机断层扫描,SPECT)上有17例患者发现99mTc-HYNIC膜联蛋白V摄取,与CT确定的病理区域相对应。在其余1例患者中,CT和99mTc-HYNIC膜联蛋白V闪烁显像均为假阴性。在11例患者中,SPECT和CT扫描结果一致,均识别出所有原发性病变及2处淋巴结受累部位。在其余6例患者中,CT和SPECT准确识别出原发性病变,但在淋巴结受累情况方面存在不一致。在这6例患者中的5例中,SPECT未识别出淋巴结受累,而CT扫描识别出了。在其余1例患者中,CT扫描对淋巴结受累呈假阳性,而SPECT未呈假阳性。在本系列研究中,99mTc-HYNIC膜联蛋白V能够使CT扫描识别出的所有原发性头颈部肿瘤可视化,但未能识别出大多数淋巴结受累部位。

相似文献

1
99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma.原发性头颈癌的99mTc-HYNIC膜联蛋白V显像
Nucl Med Commun. 2004 Mar;25(3):259-63. doi: 10.1097/00006231-200403000-00008.
2
Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography.使用锝-99m-HYNIC膜联蛋白V单光子发射计算机断层扫描进行定量肿瘤细胞凋亡成像。
J Clin Oncol. 2003 Sep 15;21(18):3483-7. doi: 10.1200/JCO.2003.12.096.
3
Prognostic value of 99mTc-HYNIC annexin-V imaging in squamous cell carcinoma of the head and neck.99mTc-HYNIC膜联蛋白V显像在头颈部鳞状细胞癌中的预后价值
Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):47-52. doi: 10.1007/s00259-007-0577-0. Epub 2007 Sep 29.
4
Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma.99mTc-HYNIC膜联蛋白V摄取与头颈部癌微血管密度、FasL和MMP-9表达以及肿瘤浸润淋巴细胞数量的关系
Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):1016-21. doi: 10.1007/s00259-004-1499-8. Epub 2004 Mar 11.
5
99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy.99mTc Hynic-rh-膜联蛋白V闪烁扫描术用于头颈部癌放化疗患者体内细胞凋亡成像
Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):509-18. doi: 10.1007/s00259-007-0624-x. Epub 2007 Nov 10.
6
The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.99mTc-替曲膦单光子发射计算机断层扫描在检测肺外原发性肿瘤肺转移中的应用价值。
Radiol Med. 2004 Jan-Feb;107(1-2):113-27.
7
Intraobserver, interobserver, and day-to-day reproducibility of quantitative 99mTc-HYNIC annexin-V imaging in head and neck carcinoma.头颈部癌中定量99mTc-HYNIC膜联蛋白V成像的观察者内、观察者间及日常可重复性
Cancer Biother Radiopharm. 2004 Apr;19(2):205-10. doi: 10.1089/108497804323071986.
8
Imaging of regional lymph node metastases with 99mTc-depreotide in patients with lung cancer.肺癌患者使用99mTc-去甲奥曲肽对区域淋巴结转移灶进行成像。
Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):925-31. doi: 10.1007/s00259-005-1800-5. Epub 2005 Apr 20.
9
Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusion.正常结构中治疗诱导凋亡的映射:99mTc-Hynic-rh-膜联蛋白V单光子发射计算机断层显像与计算机断层扫描图像融合
Eur J Nucl Med Mol Imaging. 2006 Aug;33(8):893-9. doi: 10.1007/s00259-006-0070-1. Epub 2006 Apr 4.
10
Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.锝-99m-甲氧基异丁基异腈在原发性和复发性头颈部肿瘤中的应用:骨SPECT图像融合的作用
J Nucl Med. 1998 Jul;39(7):1166-71.

引用本文的文献

1
Radionuclide imaging of apoptosis for clinical application.放射性核素凋亡显像的临床应用。
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1345-1359. doi: 10.1007/s00259-021-05641-4. Epub 2021 Dec 7.
2
Apoptosis Imaging in Oncology by Means of Positron Emission Tomography: A Review.正电子发射断层扫描在肿瘤学中的细胞凋亡成像:综述。
Int J Mol Sci. 2021 Mar 9;22(5):2753. doi: 10.3390/ijms22052753.
3
Avenues to molecular imaging of dying cells: Focus on cancer.濒死细胞的分子影像学途径:以癌症为例。
Med Res Rev. 2018 Sep;38(6):1713-1768. doi: 10.1002/med.21495. Epub 2018 Mar 12.
4
Preliminary biological evaluation of F-AlF-NOTA-MAL-Cys-Annexin V as a novel apoptosis imaging agent.F-AlF-NOTA-MAL-Cys-膜联蛋白V作为新型凋亡显像剂的初步生物学评价
Oncotarget. 2017 Apr 10;8(31):51086-51095. doi: 10.18632/oncotarget.16994. eCollection 2017 Aug 1.
5
Preclinical Evaluation of F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid Tumors.F-ML-10的临床前评估以确定实体瘤对化疗凋亡反应的时间。
Mol Imaging. 2017 Jan 1;16:1536012116685941. doi: 10.1177/1536012116685941.
6
Semi-automatic synthesis and biodistribution of N-(2-F-fluoropropionyl)-bis(zinc (II)-dipicolylamine) (F-FP-DPAZn2) for AD model imaging.用于阿尔茨海默病模型成像的N-(2-氟丙酰基)-双(锌(II)-二吡啶甲胺)(F-FP-DPAZn2)的半自动合成及生物分布
BMC Med Imaging. 2017 Apr 21;17(1):27. doi: 10.1186/s12880-017-0200-1.
7
SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic.用于细胞凋亡分子成像的单光子发射计算机断层扫描(SPECT)和正电子发射断层扫描(PET)放射性药物:从实验台到临床
Oncotarget. 2017 Mar 21;8(12):20476-20495. doi: 10.18632/oncotarget.14730.
8
(99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.(99m)锝标记膜联蛋白A5对凋亡肿瘤反应的定量分析:临床影像学试验的系统评价和荟萃分析
Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2083-97. doi: 10.1007/s00259-015-3152-0. Epub 2015 Aug 16.
9
99mTc-HYNIC-Annexin A5 in Oncology: Evaluating Efficacy of Anti-Cancer Therapies.99mTc-HYNIC-膜联蛋白 A5 在肿瘤学中的应用:评估抗癌疗法的疗效。
Cancers (Basel). 2013 May 15;5(2):550-68. doi: 10.3390/cancers5020550.
10
In vitro and in vivo evaluation of the caspase-3 substrate-based radiotracer [(18)F]-CP18 for PET imaging of apoptosis in tumors.基于半胱天冬酶-3 底物的放射性示踪剂 [(18)F]-CP18 的体外和体内评估用于肿瘤细胞凋亡的 PET 成像。
Mol Imaging Biol. 2013 Dec;15(6):748-57. doi: 10.1007/s11307-013-0646-7.